Abstract:Childhood trauma (CT) is associated with increased inflammation, independently, and comorbidly with, depression. There is also evidence for differential inflammatory gene expression in depression treatment response. Previous analysis identified a trend for the role of CT on NR3C1 expression, however, differences were attributable to depression treatment response. The present work explores the role of CT in inflammation and depression treatment response. The BIOmarkers in DEPression study recruited 170 participants as controls (n=40), responders (n=36), treatment-resistant depressed (TRD) (n=58), or untreated-depressed (UD)(n=36). The Hamilton Depression Rating Scale measured depression. CT was categorised as none-low (n=90), or moderate-severe trauma (n=80) according to the Childhood Trauma Questionnaire. mRNA quantitative polymerase chain reaction (qPCR) measured 7 candidate inflammatory gene expression: A2M, FKBP5, IL6, MIF, SGK1, STAT1, and TNF. Univariate analyses explored inflammatory gene expression differences across CT and treatment response groups. CT did not play a significant role in the differential expression; depression treatment response groups were significantly associated with increased A2M (p<.001), FKBP5 (p<.001), IL6 (p<.001), MIF (p<.001), SGK1 (p<.001) and TNF (p<.001). Responders showed highest mean A2M (.821, SE=.015) and IL-6 expression (.820, SE=.012); TRD showed highest FKBP5 (.819, SE=.010) and TNF (.840, SE=.008); UD participants showed the highest MIF (.832, SE=.013), SGK1 (.801, SE=.008) and STAT1 (.800, SE=.014). Despite a previous trend for CT in NR3C1 expression, increases in further inflammatory gene expression were driven by differences in depression treatment response, with no effect of CT.

- Inflammatory gene expression differences observed in depression treatment response groups: exploring the role of childhood trauma